Ghost Tree Capital as of March 31, 2015
Portfolio Holdings for Ghost Tree Capital
Ghost Tree Capital holds 62 positions in its portfolio as reported in the March 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| SPDR S&P Biotech (XBI) | 8.1 | $23M | 100k | 225.50 | |
| NuVasive | 4.3 | $12M | 260k | 45.99 | |
| Zimmer Holdings (ZBH) | 4.2 | $12M | 100k | 117.52 | |
| Actavis | 3.8 | $10M | 35k | 297.63 | |
| Avalanche Biotechnologies In | 3.1 | $8.5M | 210k | 40.52 | |
| Endo Pharmaceuticals Hldgs I note 1.750% 4/1 | 2.9 | $8.1M | 90k | 89.70 | |
| Community Health Systems (CYH) | 2.8 | $7.8M | 150k | 52.28 | |
| Puma Biotechnology (PBYI) | 2.5 | $7.1M | 30k | 236.10 | |
| Zs Pharma | 2.5 | $6.9M | 165k | 42.08 | |
| Celgene Corporation | 2.5 | $6.9M | 60k | 115.28 | |
| Zeltiq Aesthetics | 2.5 | $6.9M | 225k | 30.83 | |
| Portola Pharmaceuticals | 2.5 | $6.8M | 180k | 37.96 | |
| Sage Therapeutics (SAGE) | 2.2 | $6.0M | 120k | 50.23 | |
| Dyax | 2.1 | $5.9M | 350k | 16.75 | |
| Merit Medical Systems (MMSI) | 2.1 | $5.8M | 300k | 19.25 | |
| Merck & Co (MRK) | 2.1 | $5.7M | 100k | 57.48 | |
| Wright Medical | 1.9 | $5.2M | 200k | 25.80 | |
| Becton, Dickinson and (BDX) | 1.8 | $5.0M | 35k | 143.60 | |
| Genocea Biosciences | 1.8 | $5.0M | 420k | 11.86 | |
| Alcobra | 1.6 | $4.5M | 800k | 5.63 | |
| BioMarin Pharmaceutical (BMRN) | 1.6 | $4.4M | 35k | 124.63 | |
| Sunesis Pharmaceuticals | 1.5 | $4.3M | 1.8M | 2.45 | |
| Cepheid | 1.5 | $4.3M | 75k | 56.91 | |
| Alnylam Pharmaceuticals (ALNY) | 1.5 | $4.2M | 40k | 104.42 | |
| Agilent Technologies Inc C ommon (A) | 1.5 | $4.2M | 100k | 41.55 | |
| Revance Therapeutics (RVNC) | 1.5 | $4.1M | 200k | 20.73 | |
| Abbvie (ABBV) | 1.5 | $4.1M | 70k | 58.54 | |
| Gw Pharmaceuticals Plc ads | 1.5 | $4.1M | 45k | 91.13 | |
| ACADIA Pharmaceuticals (ACAD) | 1.4 | $3.9M | 120k | 32.59 | |
| EXACT Sciences Corporation (EXAS) | 1.4 | $3.9M | 175k | 22.02 | |
| Amicus Therapeutics (FOLD) | 1.4 | $3.8M | 350k | 10.88 | |
| Achillion Pharmaceuticals | 1.3 | $3.7M | 375k | 9.86 | |
| Therapeuticsmd | 1.3 | $3.6M | 600k | 6.05 | |
| Ptc Therapeutics I (PTCT) | 1.3 | $3.7M | 60k | 60.85 | |
| Bluebird Bio (BLUE) | 1.3 | $3.6M | 30k | 120.77 | |
| Flamel Technologies | 1.3 | $3.6M | 200k | 17.98 | |
| Inogen (INGN) | 1.3 | $3.5M | 110k | 31.99 | |
| Vitae Pharmaceuticals | 1.3 | $3.5M | 300k | 11.71 | |
| Dbv Technologies S A (DBVT) | 1.3 | $3.5M | 150k | 23.36 | |
| Nanostring Technologies (NSTGQ) | 1.2 | $3.4M | 335k | 10.19 | |
| Entellus Medical Cm | 1.2 | $3.3M | 150k | 21.90 | |
| Radius Health | 1.1 | $3.1M | 75k | 41.16 | |
| Discovery Laboratories | 1.1 | $3.0M | 2.5M | 1.19 | |
| Pernix Therapeutics Holdings | 1.0 | $2.7M | 250k | 10.69 | |
| Ignyta | 0.9 | $2.5M | 250k | 9.95 | |
| Lion Biotechnologies | 0.9 | $2.4M | 200k | 12.11 | |
| Tetraphase Pharmaceuticals | 0.9 | $2.4M | 65k | 36.65 | |
| Applied Genetic Technol Corp C | 0.8 | $2.3M | 117k | 19.99 | |
| Five Prime Therapeutics | 0.8 | $2.3M | 100k | 22.85 | |
| Epizyme | 0.8 | $2.2M | 115k | 18.78 | |
| Loxo Oncology | 0.8 | $2.2M | 175k | 12.45 | |
| BioDelivery Sciences International | 0.8 | $2.1M | 200k | 10.50 | |
| Celladon | 0.7 | $1.9M | 100k | 18.94 | |
| Unilife US | 0.7 | $1.8M | 450k | 4.01 | |
| Advaxis | 0.7 | $1.8M | 125k | 14.44 | |
| Insulet Corporation (PODD) | 0.6 | $1.7M | 50k | 33.36 | |
| Assembly Biosciences | 0.6 | $1.7M | 125k | 13.24 | |
| Kindred Biosciences | 0.3 | $718k | 101k | 7.14 | |
| Biolase Technology | 0.2 | $606k | 300k | 2.02 | |
| Ocera Therapeutics | 0.2 | $589k | 125k | 4.71 | |
| Globeimmune (GBIM) | 0.2 | $506k | 69k | 7.34 | |
| XOMA CORP Common equity shares | 0.1 | $262k | 72k | 3.64 |
